End-of-life targeted auxin-mediated degradation of DAF-2 Insulin/IGF-1 receptor promotes longevity free from growth-related pathologies

  1. Richard Venz
  2. Tina Pekec
  3. Iskra Katic
  4. Rafal Ciosk
  5. Collin Yvès Ewald  Is a corresponding author
  1. Swiss Federal Institute of Technology in Zurich, Switzerland
  2. Friedrich Miescher Institute, Switzerland
  3. University of Oslo, Norway

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received
  5. Preprint posted

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Richard Venz
  2. Tina Pekec
  3. Iskra Katic
  4. Rafal Ciosk
  5. Collin Yvès Ewald
(2021)
End-of-life targeted auxin-mediated degradation of DAF-2 Insulin/IGF-1 receptor promotes longevity free from growth-related pathologies
eLife 10:e71335.
https://doi.org/10.7554/eLife.71335

Share this article

https://doi.org/10.7554/eLife.71335